- Home
- UNCY vs RDZN Comparison
UNCY vs RDZN Comparison
Compare UNCY & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- RDZN
- Stock Information
- Founded
- UNCY 2016
- RDZN 2015
- Country
- UNCY United States
- RDZN United States
- Employees
- UNCY N/A
- RDZN N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- RDZN Blank Checks
- Sector
- UNCY Health Care
- RDZN Finance
- Exchange
- UNCY Nasdaq
- RDZN Nasdaq
- Market Cap
- UNCY 74.2M
- RDZN 75.2M
- IPO Year
- UNCY 2021
- RDZN N/A
- Fundamental
- Price
- UNCY $3.94
- RDZN $0.96
- Analyst Decision
- UNCY Strong Buy
- RDZN Strong Buy
- Analyst Count
- UNCY 5
- RDZN 2
- Target Price
- UNCY $55.20
- RDZN $5.00
- AVG Volume (30 Days)
- UNCY 520.0K
- RDZN 202.5K
- Earning Date
- UNCY 11-12-2025
- RDZN 11-12-2025
- Dividend Yield
- UNCY N/A
- RDZN N/A
- EPS Growth
- UNCY N/A
- RDZN N/A
- EPS
- UNCY N/A
- RDZN N/A
- Revenue
- UNCY N/A
- RDZN $46,230,126.00
- Revenue This Year
- UNCY N/A
- RDZN $38.45
- Revenue Next Year
- UNCY $4,481.14
- RDZN $66.38
- P/E Ratio
- UNCY N/A
- RDZN N/A
- Revenue Growth
- UNCY N/A
- RDZN N/A
- 52 Week Low
- UNCY $3.40
- RDZN $0.68
- 52 Week High
- UNCY $11.00
- RDZN $2.99
- Technical
- Relative Strength Index (RSI)
- UNCY 37.53
- RDZN 42.09
- Support Level
- UNCY $4.23
- RDZN $0.93
- Resistance Level
- UNCY $4.43
- RDZN $1.00
- Average True Range (ATR)
- UNCY 0.19
- RDZN 0.06
- MACD
- UNCY -0.01
- RDZN 0.00
- Stochastic Oscillator
- UNCY 22.22
- RDZN 34.94
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.